ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer

Triple negative breast cancer (TNBC), which comprises approximately 15% of all primary breast cancer diagnoses, lacks estrogen receptor alpha, progesterone receptor and human epidermal growth factor receptor 2 expression. However, we, and others, have demonstrated that approximately 30% of TNBCs exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Reese, Jordan M., Bruinsma, Elizabeth S., Monroe, David G., Negron, Vivian, Suman, Vera J., Ingle, James N., Goetz, Matthew P., Hawse, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722501/
https://www.ncbi.nlm.nih.gov/pubmed/29228549
http://dx.doi.org/10.18632/oncotarget.21787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722501/
https://www.ncbi.nlm.nih.gov/pubmed/29228549
http://dx.doi.org/10.18632/oncotarget.21787

Ejemplares similares